Back

Validating HIV viral suppression threshold adjustments for comparable estimates using data from nationally representative household surveys in sub-Saharan Africa

Edun, O.; Okell, L.; Wolock, T. M.; Korenromp, E. L.; johnson, L. F.; Imai-Eaton, J. W.

2025-04-10 hiv aids
10.1101/2025.04.09.25325517 medRxiv
Show abstract

IntroductionTo enable comparable global assessments of viral load suppression (VLS) among people living with HIV on antiretroviral therapy (ART), UNAIDS applies a model to adjust VLS estimates reported at different thresholds to a common VL [&le;]1000 copies/mL definition. We assessed performance of the current reverse Weibull model and alternatives using survey data from sub-Saharan Africa. MethodsUsing data from 21 Population-based HIV Impact Assessment surveys (PHIAs) in 16 sub-Saharan African countries (2015-2022), we assessed six models (Weibull, reverse Weibull, Pareto, Frechet, gamma, and lognormal) in adjusting VLS reported at VL <50, <200, <400 copies/mL to [&le;]1000. We compared predictions using parameters from Johnson et al. and recalibrated using PHIAs, assessing whether new shape parameters improved adjustments and varied by sex and age. ResultsIn adjustments from all thresholds, the Weibull model had the lowest prediction errors (Root-mean-squared error for <200 to [&le;]1000: Weibull: 1.9%; reverse Weibull: 3.1%; Pareto: 2.5%). Prediction errors for reverse Weibull and Pareto models were higher in subgroups with low VLS, compared to Weibull. Across 21 surveys, in adjustments from <200 to [&le;]1000, reverse Weibull overestimated VLS by 2.3%, compared to 1.5% by Weibull and Pareto. The Frechet, gamma, and lognormal models performed similarly to Weibull. Shape parameter estimates for the Weibull and reverse Weibull were slightly higher after recalibration and varied by sex and age. ConclusionThe Weibull, Frechet, gamma, and lognormal models, provided more reliable VLS adjustments across thresholds than the previously recommended reverse Weibull model, avoiding inflated VLS estimates which could obscure gaps in HIV treatment programmes and underestimate HIV transmission risks.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
AIDS
31 papers in training set
Top 0.1%
18.3%
2
JAIDS Journal of Acquired Immune Deficiency Syndromes
19 papers in training set
Top 0.1%
14.1%
3
PLOS ONE
4510 papers in training set
Top 19%
9.9%
4
Journal of the International AIDS Society
20 papers in training set
Top 0.1%
8.3%
50% of probability mass above
5
PLOS Computational Biology
1633 papers in training set
Top 8%
4.1%
6
BMJ Open
554 papers in training set
Top 5%
3.9%
7
American Journal of Epidemiology
57 papers in training set
Top 0.3%
3.5%
8
The Lancet Global Health
24 papers in training set
Top 0.4%
3.0%
9
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.7%
10
Journal of The Royal Society Interface
189 papers in training set
Top 2%
2.7%
11
Epidemics
104 papers in training set
Top 0.6%
2.6%
12
PLOS Medicine
98 papers in training set
Top 2%
2.3%
13
BMJ Global Health
98 papers in training set
Top 1%
2.0%
14
International Journal of Infectious Diseases
126 papers in training set
Top 1%
2.0%
15
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
16
JAMA Network Open
127 papers in training set
Top 2%
1.7%
17
AIDS and Behavior
14 papers in training set
Top 0.3%
1.7%
18
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.6%
19
Nature Communications
4913 papers in training set
Top 60%
0.9%
20
International Journal of Medical Informatics
25 papers in training set
Top 2%
0.8%
21
Infectious Diseases of Poverty
10 papers in training set
Top 0.4%
0.7%
22
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.7%
23
Sexually Transmitted Infections
21 papers in training set
Top 0.4%
0.7%
24
PLOS Global Public Health
293 papers in training set
Top 6%
0.6%